Patent Assignment
Reel/Frame 060096/0039
Security Interest
Recorded: 2022-06-03
Pages: 8
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
601 LEXINGTON AVENUE, 54TH FLOOR, C/O ORBIMED ADVISORS LLC, NEW YORK, NEW YORK, 10022
Covered Properties
(10)
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
17/319,221 →
Publication:
US 2021/0275444
Rho Kinase Inhibitor Ba-1049 (R) and Active Metabolites Thereof
Intranasal Epinephrine Formulations and Methods for the Treatment of Disease
Methods and Compositions for Rapid Delivery of Anti-Seizure Therapeutics
Application:
17/570,535 →
Publication:
US 2022/0218598
Administration of Benzodiazepine Compositions
Compositions and Methods for the Treatment of Opioid Overdose
Application:
63/229,300 →
Methods and Compositions for Rapid Delivery of Anti-Seizure Therapeutics
Application:
63/276,760 →
Compositions and Methods for Single Dose Anti-Seizure Therapeutics
Application:
63/276,761 →
Methods and Compositions for Increasing Interseizure Cluster Interval Duration
Application:
63/284,033 →
Intranasal Olanzapine Formulations and Methods of Their Use
Application:
63/323,592 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 13, 2021
From: CRYSTAL, ROGER; SKOLNICK, PHIL
To: OPIANT PHARMACEUTICALS, INC.
Reel/Frame 056227/0902 →
Assignment of Assignor's Interest
Jul 21, 2021
From: ROSEN, KENNETH M.; ABBINANTI, MATTHEW D.; RUSCHEL, JOERG; MCKERRACHER, LISA
To: BIOAXONE BIOSCIENCES, INC.
Reel/Frame 056932/0377 →
Assignment of Assignor's Interest
Sep 14, 2021
From: ARS PHARMACEUTICALS INC.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 057481/0511 →
Assignment of Assignor's Interest
Sep 14, 2021
From: LOWENTHAL, RICHARD; SHAH, PRATIK; BELL, ROBERT G.
To: ARS PHARMACEUTICALS INC.
Reel/Frame 057481/0488 →
Assignment of Assignor's Interest
Sep 14, 2021
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 057481/0378 →
Assignment of Assignor's Interest
Nov 17, 2021
From: MAGGIO, EDWARD T.
To: NEURELIS, INC.
Reel/Frame 058133/0053 →
Assignment of Assignor's Interest
Nov 17, 2021
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 058133/0058 →
Assignment of Assignor's Interest
Nov 17, 2021
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 058132/0947 →
Assignment of Assignor's Interest
Nov 17, 2021
From: MAGGIO, EDWARD T.
To: NEURELIS, INC.
Reel/Frame 058132/0923 →
Assignment of Assignor's Interest
Jan 10, 2022
From: MISRA, SUNITA
To: NEURELIS, INC.
Reel/Frame 058605/0082 →
Assignment of Assignor's Interest
Jan 10, 2022
From: RABINOWICZ, ADRIAN L.
To: NEURELIS, INC.
Reel/Frame 058604/0931 →
Assignment of Assignor's Interest
Jan 10, 2022
From: CARRAZANA, ENRIQUE J.
To: NEURELIS, INC.
Reel/Frame 058604/0972 →
Assignment of Assignor's Interest
Feb 10, 2022
From: MAGGIO, EDWARD T.
To: AEGIS THERAPEUTICS, LLC
Reel/Frame 058984/0188 →
Assignment of Assignor's Interest
Mar 29, 2022
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 059420/0361 →
Assignment of Assignor's Interest
Apr 15, 2022
From: HALE BIOPHARMA VENTURES, LLC
To: NEURELIS, INC.
Reel/Frame 059609/0702 →
Assignment of Assignor's Interest
Apr 15, 2022
From: CARTT, STEVE; MEDEIROS, DAVID; GWOZDZ, GARRY THOMAS; LOXLEY, ANDREW
To: HALE BIOPHARMA VENTURES, LLC
Reel/Frame 059609/0658 →
Assignment of Assignor's Interest
May 3, 2022
From: RABINOWICZ, ADRIAN L.
To: NEURELIS, INC.
Reel/Frame 059798/0076 →
Assignment of Assignor's Interest
May 3, 2022
From: MADDEN, STUART
To: NEURELIS, INC.
Reel/Frame 059798/0152 →
Assignment of Assignor's Interest
May 3, 2022
From: CARRAZANA, ENRIQUE J.
To: NEURELIS, INC.
Reel/Frame 059798/0050 →
Assignment of Assignor's Interest
May 3, 2022
From: MISRA, SUNITA
To: NEURELIS, INC.
Reel/Frame 059797/0994 →
Assignment of Assignor's Interest
May 3, 2022
From: MAGGIO, EDWARD T.
To: NEURELIS, INC.
Reel/Frame 059798/0239 →
Assignment of Assignor's Interest
Jun 21, 2023
From: GUSTIN, RICHARD MICHAEL
To: NEURELIS, INC.
Reel/Frame 064014/0141 →
Assignment of Assignor's Interest
Jun 22, 2023
From: RABINOWICZ, ADRIAN L.; CARRAZANA, ENRIQUE J.
To: NEURELIS, INC.
Reel/Frame 064025/0229 →
Security Interest
Nov 14, 2024
From: AEGIS THERAPEUTICS, LLC
To: NEF ROYALTY SUB LLC
Reel/Frame 069261/0553 →
Release of Security Interest
Nov 14, 2024
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: NEURELIS, INC.; AEGIS THERAPEUTICS, LLC
Reel/Frame 069359/0921 →